Allied Market Research published a report, titled, “Software As A Medical Device Market by Deployment Type (Cloud Based and On Premise), Application (Screening and Diagnosis, Monitoring and Alerting, Chronic Disease Management, Digital Therapeutics and Others), and End User (Hospitals and Clinics, Home Care Settings and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033″. According to the report, the (SaMD) software as a medical device market was valued at $19.5 million in 2023, and is estimated to reach $96.2 million by 2033, growing at a CAGR of 17.3% from 2024 to 2033.
Prime determinants of growth
Growing prevalence of chronic diseases, rise in technological advancements in medical software, and growing adoption of telehealth solutions are the major factors that drive the growth of the (SaMD) software as a medical device market growth. However, Data security and privacy concerns restrict the market growth. Moreover, government initiatives for healthcare digitization and high growth potential in emerging countries offer remunerative opportunities for the expansion of the global (SaMD) software as a medical device market.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐: https://www.alliedmarketresearch.com/request-sample/3593
๐๐จ๐ฉ ๐๐จ๐๐ญ๐ฐ๐๐ซ๐ ๐๐ฌ ๐ ๐๐๐๐ข๐๐๐ฅ ๐๐๐ฏ๐ข๐๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ
- MindMaze
- Siemens
- Biofourmis
- BrightInsight, Inc.
- 4S Information Systems Ltd,
- ai, Inc.
- Hoffmann-La Roche Ltd
- Koninklijke Philips N.V.,
- Orthogonal
- Zรผhlke Engineering AG
๐๐จ๐๐ญ๐ฐ๐๐ซ๐ ๐๐ฌ ๐ ๐๐๐๐ข๐๐๐ฅ ๐๐๐ฏ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐๐๐ง ๐๐ ๐๐จ๐ง๐ ๐๐๐ฌ๐๐ ๐จ๐ง ๐ฌ๐๐ฏ๐๐ซ๐๐ฅ ๐๐๐๐ญ๐จ๐ซ๐ฌ, ๐ข๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ :
By deployment type, the cloud-based segment plays a pivotal role in software as a medical device (SaMD) market owing to scalability, flexibility, and cost-effectiveness of cloud solutions, which offer enhanced data storage, management, and accessibility. Cloud-based SaMDs facilitate seamless updates and integration, ensuring up-to-date functionalities and compliance with evolving regulations. In addition, cloud-based solutions provide robust data security measures and support real-time data analytics, crucial for effective patient monitoring and treatment. The global shift towards digital healthcare and remote patient management further propelled the adoption of cloud-based SaMD solutions.
By application, the screening and diagnosis segment is driven by the increase in demand for early disease detection and the integration of AI and machine learning for improved diagnostic accuracy. In addition, advancements in imaging software and the growing prevalence of chronic diseases have driven the need for reliable diagnostic tools which further support the segment growth. Moreover, regulatory bodies are increasingly approving innovative diagnostic software, bolstering market expansion.
By end user, the hospitals and clinics segment serve as primary hubs for patient care, where the adoption of digital health technologies is integral to enhancing operational efficiency and patient outcomes. Increasing digitization of healthcare records and the need for seamless data management drive the demand for SaMD solutions within these settings. Further, hospitals and clinics often have the resources and infrastructure to invest in advanced medical technologies, including SaMD, to improve diagnostic accuracy, treatment efficacy, and patient monitoring.
North America held a leading position in the software as a medical device (SaMD) market share owing to advanced healthcare infrastructure and strong presence of major technology companies foster innovation and development in SaMD solutions. Robust regulatory frameworks, such as the FDA’s guidelines for digital health, ensure the safety and efficacy of these devices, encouraging market growth. High investment in healthcare IT and widespread adoption of digital health technologies also contribute significantly. In addition, increasing prevalence of chronic diseases and a tech-savvy population drive the demand for advanced diagnostic and monitoring tools.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/3593
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
- Which region has more opportunities?
By Region Outlook
- North America
(U.S., Canada, Mexico)
- Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
- Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
- LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
